Last reviewed · How we verify
CRISPR_SCD001
At a glance
| Generic name | CRISPR_SCD001 |
|---|---|
| Sponsor | Mark Walters, MD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CRISPR_SCD001 CI brief — competitive landscape report
- CRISPR_SCD001 updates RSS · CI watch RSS
- Mark Walters, MD portfolio CI